Literature DB >> 23047792

Effect of a life review program for Chinese patients with advanced cancer: a randomized controlled trial.

Huimin Xiao1, Enid Kwong, Samantha Pang, Esther Mok.   

Abstract

BACKGROUND: Empirical data suggest that life review is an effective psychospiritual intervention. However, it has not been applied to Chinese patients with advanced cancer, and its effects on this population remain unknown.
OBJECTIVE: The aim of the study was to determine the effect of a life review program on quality of life among Chinese patients with advanced cancer.
METHODS: In this prospective randomized controlled trial, a total of 80 patients were randomly assigned to the life review program group and the control group. The 3-weekly life review program included reviewing a life and formulating a life review booklet. Outcome data were assessed by a collector who was blinded to group assignment before and immediately after the program and at a 3-week follow-up.
RESULTS: Significantly better scores in overall quality of life, support, negative emotions, sense of alienation, existential distress, and value of life were found in the life review group immediately after the program and at the 3-week follow-up.
CONCLUSION: This study provides additional data on the potential role of a life review in improving quality of life, particularly psychospiritual well being; it also indicates that the life review program could enable Chinese patients with advanced cancer to express their views on life and death. IMPLICATIONS FOR PRACTICE: The life review program offers advanced cancer patients an opportunity to integrate their whole life experiences and discuss end-of-life issues, which lays the ground for further active intervention in their psychospiritual distress. The program could be integrated into daily home care to enhance the psychospiritual well-being of Chinese patients with advanced cancer.

Entities:  

Mesh:

Year:  2013        PMID: 23047792     DOI: 10.1097/NCC.0b013e318268f7ba

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  6 in total

Review 1.  Effects of psychosocial interventions on meaning and purpose in adults with cancer: A systematic review and meta-analysis.

Authors:  Crystal L Park; James E Pustejovsky; Kelly Trevino; Allen C Sherman; Craig Esposito; Mark Berendsen; John M Salsman
Journal:  Cancer       Date:  2019-04-29       Impact factor: 6.860

2.  The Effect of Dignity Therapy on the Quality of Life of Patients with Cancer Receiving Palliative Care.

Authors:  Mahsa Zaki-Nejad; Alireza Nikbakht-Nasrabadi; Arpi Manookian; Ahmadreza Shamshiri
Journal:  Iran J Nurs Midwifery Res       Date:  2020-06-17

3.  A cognitive-existential intervention to improve existential and global quality of life in cancer patients: A pilot study.

Authors:  Pierre Gagnon; Lise Fillion; Marie-Anik Robitaille; Michèle Girard; François Tardif; Jean-Philippe Cochrane; Joanie Le Moignan Moreau; William Breitbart
Journal:  Palliat Support Care       Date:  2014-07-22

4.  Development and evaluation of a WeChat-based life review programme for patients with cancer: protocol for a randomised controlled trial.

Authors:  Xiaoling Zhang; Huimin Xiao
Journal:  BMJ Open       Date:  2018-12-06       Impact factor: 2.692

Review 5.  The Present State of Existential Interventions Within Palliative Care.

Authors:  Takeshi Terao; Moriaki Satoh
Journal:  Front Psychiatry       Date:  2022-01-13       Impact factor: 4.157

6.  The efficacy of Life Review Therapy combined with Memory Specificity Training (LRT-MST) targeting cancer patients in palliative care: A randomized controlled trial.

Authors:  Gitta Kleijn; Birgit I Lissenberg-Witte; Ernst T Bohlmeijer; Bas Steunenberg; Kitty Knipscheer-Kuijpers; Vincent Willemsen; Annemarie Becker; Egbert F Smit; Corien M Eeltink; Anna M E Bruynzeel; Maurice van der Vorst; Remco de Bree; C René Leemans; Michiel W M van den Brekel; Pim Cuijpers; Irma M Verdonck-de Leeuw
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.